Total-body PET scan maps HER2 tracer in breast cancer and finds earlier imaging window
A dynamic total-body PET/CT study of Ga-HER2 Affibody in HER2-positive breast cancer patients measured organ biodistribution, an effective dose of ...
A dynamic total-body PET/CT study of Ga-HER2 Affibody in HER2-positive breast cancer patients measured organ biodistribution, an effective dose of ...
A multi-vendor study demonstrates that pairing low-dose brain computed tomography with hybrid statistical iterative reconstruction cuts radiation dose by roughly ...
A retrospective single-center study of 76 prostate cancer patients found that raising the injected activity of Lu-PSMA-I&T from 7.4 to ...
A letter in EJNMMI Reports argues that tumour SUVmean and volume act as surrogates for the radiation absorbed dose that ...
A retrospective study of 33 right-sided breast cancer patients links simple target volume measurements on planning CT scans to higher ...
Researchers have formulated a GMP-quality kit for preparing a zirconium-89 labelled pembrolizumab PET imaging agent, with preclinical studies supporting safety ...
In mice bearing SSTR2-H69 xenografts, terbium-161-labeled DOTA-TATE and DOTA-JR11 matched lutetium-177 at 20 Gy tumor dose and outperformed it at ...
A study of 31 patients shows pre-therapy PET metrics can predict absorbed radiation dose to tumors and organs during prostate ...
A new review finds that radioligand therapy with 131I-mIBG and 177Lu-DOTATATE offers high disease control in progressive pheochromocytomas and paragangliomas, ...
A prospective paired study of 55 patients found that a novel 3D-printed free-assembled interstitial template improved target dose coverage and ...
A phantom-based study reports that quantitative planar imaging of silver-111 is feasible when optimized triple-energy window scatter correction is combined ...
A narrative review argues that photobiomodulation's strongest evidence lies in oral mucositis prevention, while inconsistent dosimetry and reporting standards hold ...
A computational study of one breast-cancer region shows that radionuclide identity and subcellular binding location jointly shape simulated cancer-cell nuclear ...
A review published in EJNMMI Radiopharmacy and Chemistry compares how the FDA, EMA and NMPA evaluate radiopharmaceuticals before clinical use ...
Monte Carlo simulations show astatine-211 delivers about 120-fold higher single-cell nuclear dose than lutetium-177, but its effectiveness depends strongly on ...
Radiolabeled atezolizumab with lutetium-177 significantly reduced tumor volumes and extended median survival in a mouse model of triple-negative breast cancer.
A retrospective analysis of 127 patients found that only 5 percent-level few exceeded 20 Gy cumulative kidney dose after lutetium-177 ...
A retrospective study analyzed 27 patients treated with transvaginal HDR-ISBT for centrally recurrent pelvic gynecologic malignancies, finding that 3D-PT-assisted implantation ...
A new Frontiers in Nuclear Medicine review proposes an evidence-gated framework that separates established PSMA and somatostatin receptor theranostics from ...
A paired dosimetric study of 22 patients found helical tomotherapy achieved steeper peak-to-valley dose gradients and better low-dose normal tissue ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.